U.S. Venture Partners

U.S. Venture Partners (USVP), established in 1981, is a long-standing venture capital firm based in Menlo Park, California, renowned for its focus on early-stage investments. The firm primarily targets opportunities within the information technology and healthcare sectors, encompassing a broad range of sub-segments. With a history spanning over four decades, USVP has built a significant presence in the venture landscape, known for identifying and nurturing innovative companies from their foundational stages.

USVP's investment strategy is centered on identifying and partnering with disruptive companies at their foundational stages, typically from Seed through Series B rounds. Within information technology, their interests span enterprise software, SaaS, cloud infrastructure, cybersecurity, data & AI, and fintech. In healthcare, they actively invest in digital health, healthcare IT, biotechnology, and medtech innovations. The firm prides itself on being a first institutional investor or an early strategic partner, providing not just capital but also operational guidance and network access to its portfolio companies.

With a robust financial foundation, USVP has raised significant capital, with its total assets under management (AUM) exceeding $4.1 billion across 14 funds. Their most recent fund, USVP XIV, closed in 2022 with $350 million, underscoring their continued commitment to early-stage venture investing. While specific initial check sizes can vary based on the stage and needs of the company, USVP typically deploys first checks ranging from approximately $1 million for Seed rounds up to $20 million for leading Series B investments. The firm has a strong track record, having made over 600 investments and achieved more than 170 exits, including numerous IPOs and M&A transactions.